Clinical Trial Update: HAT for the Treatment of Sepsis Associated With NASTI [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating HAT for sepsis associated with necrotizing soft tissue infection was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Necrotizing Soft Tissue Infection
• Sepsis

Drugs mentioned

• HAT

Snippet

Sponsor: Ascension Health | Conditions: Necrotizing Soft Tissue Infection, Sepsis | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-07-24